New HBV Infection Biomarkers: Clinical Characterization and Impact on Management

RecruitingOBSERVATIONAL
Enrollment

900

Participants

Timeline

Start Date

November 28, 2023

Primary Completion Date

November 27, 2038

Study Completion Date

November 27, 2038

Conditions
Chronic Hepatitis B Virus (HBV) Infection
Interventions
BIOLOGICAL

Collection of blood samples for the study of HBV biomarkers

The intervention involves the additional and minimal collection of two blood samples during routine care procedures (9mL in a dry tube and 9mL in a Paxgene tube). These samples are specifically collected for research purposes and will be stored in the laboratory at the Henri Mondor Biobank Platform under the responsibility of Pr Bijan Ghaleh-Marzban for 15 years. The samples will be preserved under strict conditions and may be used for future analyses related to the pathology of HBV infection or other scientific advancements, with the patient's informed consent.

Trial Locations (1)

94000

RECRUITING

Clinical Research Unit (CRU) Henri Mondor., Créteil

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER